Bio View

Bio View P/FCF

K/FCF (Kurs-til-frit-pengestrøm-forhold) for Bio View (BIOV.TA) pr. 24. okt. 2026.

P/FCF

-

Senest opdateret:

K/FCF (Kurs-til-frit-pengestrøm-forhold) for Bio View er 2026 - . K/FCF (Kurs-til-frit-pengestrøm-forhold) for Bio View var 2025 - . Det falder dermed med % lavere sammenlignet med året før.

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Bio View Aktieanalyse

Hvad laver Bio View? BioView Ltd. generates revenue through the sale and servicing of its Duet automated cell diagnostic system, designed for use in cytology, cytogenetic, hematology, and pathology laboratories. The Duet system enables automated detection, classification, analysis, and counting of cells, offering unique capabilities in analyzing both cell morphology and genetic content simultaneously. Additional products include the ALLEGRO workstation for automated scanning of FISH probes without Brightfield scanning and the ACCORD workstation for semi-automated imaging of FISH in breast cancer (Her-2/Neu) analysis and FISH on tissue. These systems target medical professionals in cancer diagnosis, minimal-residual disease monitoring, prenatal and postnatal cytogenetic analyses, sperm cell studies, and rare-cell detection. The company's primary customers are laboratories specializing in cytology, cytogenetics, hematology, and pathology, including those focused on cancer diagnostics and genetic analysis. These institutions purchase the Duet system for routine diagnostic workflows and the ALLEGRO and ACCORD workstations for specialized applications such as FISH analysis in breast cancer and genetic studies. BioView Ltd. also provides ongoing servicing and support for its systems, contributing to recurring revenue streams. BioView Ltd. markets its products under the brand names Duet, ALLEGRO, and ACCORD, with the Duet system serving as the core offering for general cell analysis. The ALLEGRO and ACCORD workstations cater to niche applications in FISH-based diagnostics, particularly in oncology and genetic testing. The company's revenue is derived from direct sales of these systems to healthcare facilities and laboratories, with no mention of third-party partnerships or additional revenue streams beyond product sales and servicing. Bio View er et af de mest populære virksomheder på Eulerpool.com.

Hyppigt stillede spørgsmål om Bio View aktie

På Eulerpool kan du finde den fuldstændige historiske udvikling af K/FCF (Kurs-til-frit-pengestrøm-forhold) Bio View siden 2006 – med årlige værdier, diagrammer og detaljeret analyse.

Kurs-til-frit-pengestrøm-forholdet måler, hvor meget investorer betaler for hver enhed frit pengestrøm. Et lavere forhold kan indikere bedre værdi.

K/FCF = Markedsværdi / Frit pengestrøm

For at evaluere K/FCF (Kurs-til-frit-pengestrøm-forhold)s er det afgørende at sammenligne det med andre virksomheder i samme branche og sektor. På Eulerpool kan du finde branchsammenligninger for K/FCF (Kurs-til-frit-pengestrøm-forhold).

En 'god' varierer efter branche og virksomhedens udviklingsstadium. På Eulerpool kan du sammenligne K/FCF (Kurs-til-frit-pengestrøm-forhold)s Bio View med konkurrenter og branchegjennemsnittet for at afgøre, om den er attraktiv.

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Værdiansættelse — Bio View

Alle nøgletal — Bio View